Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rambeck

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Therapeutic Drug Monitoring|December 16, 1998
Comparison of total and free phenytoin serum concentrations measured by high-performance liquid chromatography and standard TDx assay: implications for the prediction of free phenytoin serum concentrationsT W May, B Rambeck, U Jürges, et al.
European Neurology|January 1, 1994
Concentrations of carbamazepine and carbamazepine-10, 11-epoxide in serum, brain tumors and paratumorous cortex: a prospective study of 37 neurosurgically treated epileptic patientsR Schnabel, B Rambeck, T W May, et al.
Lancet (London, England)|July 17, 1993
Acute encephalopathy with vigabatrinA Sälke-Kellermann, H Baier, B Rambeck, et al.
Journal of the Neurological Sciences|September 15, 1996
Lack of influence of histopathological changes on carbamazepine and carbamazepine-10, 11-epoxide concentrations in the brain cortex of epileptic patientsR Schnabel, B Rambeck, T May, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn childB Rambeck, G Kurlemann, S R Stodieck, et al.
Journal of the Neurological Sciences|November 1, 1995
Lack of effect of histological lesions on the phenytoin and phenobarbital concentrations in the brain cortex of epileptic patientsR Schnabel, B Rambeck, T W May, et al.
Therapeutic Drug Monitoring|January 1, 1979
Predicting phenytoin dose - a revised nomogramB Rambeck, H E Boenigk, A Dunlop, et al.
Der Nervenarzt|August 19, 2007
[Therapeutic drug monitoring in epileptology and psychiatry]C Brandt, P Baumann, G Eckermann, et al.
Therapeutic Drug Monitoring|December 1, 1994
Comparison of phenytoin and carbamazepine serum concentrations measured by high-performance liquid chromatography, the standard TDx assay, the enzyme multiplied immunoassay technique, and a new patient-side immunoassay cartridge systemB Rambeck, T W May, M U Jürgens, et al.
Clinical Pharmacokinetics|July 1, 1983
Steady-state pharmacokinetics of phenytoin from routinely collected patient dataT H Grasela, L B Sheiner, B Rambeck, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Therapeutic Drug Monitoring|December 16, 1998
Comparison of total and free phenytoin serum concentrations measured by high-performance liquid chromatography and standard TDx assay: implications for the prediction of free phenytoin serum concentrationsT W May, B Rambeck, U Jürges, et al.
European Neurology|January 1, 1994
Concentrations of carbamazepine and carbamazepine-10, 11-epoxide in serum, brain tumors and paratumorous cortex: a prospective study of 37 neurosurgically treated epileptic patientsR Schnabel, B Rambeck, T W May, et al.
Lancet (London, England)|July 17, 1993
Acute encephalopathy with vigabatrinA Sälke-Kellermann, H Baier, B Rambeck, et al.
Journal of the Neurological Sciences|September 15, 1996
Lack of influence of histopathological changes on carbamazepine and carbamazepine-10, 11-epoxide concentrations in the brain cortex of epileptic patientsR Schnabel, B Rambeck, T May, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn childB Rambeck, G Kurlemann, S R Stodieck, et al.
Journal of the Neurological Sciences|November 1, 1995
Lack of effect of histological lesions on the phenytoin and phenobarbital concentrations in the brain cortex of epileptic patientsR Schnabel, B Rambeck, T W May, et al.
Therapeutic Drug Monitoring|January 1, 1979
Predicting phenytoin dose - a revised nomogramB Rambeck, H E Boenigk, A Dunlop, et al.
Der Nervenarzt|August 19, 2007
[Therapeutic drug monitoring in epileptology and psychiatry]C Brandt, P Baumann, G Eckermann, et al.
Therapeutic Drug Monitoring|December 1, 1994
Comparison of phenytoin and carbamazepine serum concentrations measured by high-performance liquid chromatography, the standard TDx assay, the enzyme multiplied immunoassay technique, and a new patient-side immunoassay cartridge systemB Rambeck, T W May, M U Jürgens, et al.
Clinical Pharmacokinetics|July 1, 1983
Steady-state pharmacokinetics of phenytoin from routinely collected patient dataT H Grasela, L B Sheiner, B Rambeck, et al.
Pageof 6